Natural history of venous thromboembolism.

PubWeight™: 3.67‹?› | Rank: Top 1%

🔗 View Article (PMID 12814982)

Published in Circulation on June 17, 2003

Authors

Clive Kearon1

Author Affiliations

1: McMaster Clinic, Henderson General Hospital, Hamilton, Ontario, Canada. kearonc@mcmaster.ca

Associated clinical trials:

Comparison of Accidents and Their Circumstances With Oral Anticoagulants (CACAO) | NCT02376777

Venous Thromboembolism in Myotonic Dystrophy Type 1 (DM1-VTE) | NCT03424460

Articles citing this

Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest (2012) 10.75

Dabigatran, rivaroxaban, or apixaban versus enoxaparin for thromboprophylaxis after total hip or knee replacement: systematic review, meta-analysis, and indirect treatment comparisons. BMJ (2012) 2.99

Cost-effectiveness of strategies for diagnosing pulmonary embolism among emergency department patients presenting with undifferentiated symptoms. Ann Emerg Med (2010) 2.19

The diagnosis and treatment of acute pulmonary embolism. Dtsch Arztebl Int (2010) 1.96

Postoperative enoxaparin prevents symptomatic venous thromboembolism in high-risk plastic surgery patients. Plast Reconstr Surg (2011) 1.65

Deep vein thrombosis: a clinical review. J Blood Med (2011) 1.15

Iliac vein compression as risk factor for left- versus right-sided deep venous thrombosis: case-control study. Radiology (2012) 1.12

Venous thromboembolism in thermally injured patients: analysis of the National Burn Repository. J Burn Care Res (2011) 1.07

A validated risk model to predict 90-day VTE events in postsurgical patients. Chest (2014) 0.99

Treatment options for venous thromboembolism: lessons learnt from clinical trials. Thromb J (2014) 0.95

Impact of once-daily versus twice-daily dosing frequency on adherence to chronic medications among patients with venous thromboembolism. Patient (2013) 0.94

The effect of postoperative enoxaparin on risk for reoperative hematoma. Plast Reconstr Surg (2012) 0.92

Comparative cost-effectiveness of bazedoxifene and raloxifene in the treatment of postmenopausal osteoporosis in Europe, using the FRAX algorithm. Osteoporos Int (2013) 0.92

Diagnostic accuracy of point-of-care testing for acute coronary syndromes, heart failure and thromboembolic events in primary care: a cluster-randomised controlled trial. BMC Fam Pract (2011) 0.91

Venous thromboembolism in Korean patients undergoing major orthopedic surgery: a prospective observational study using computed tomographic (CT) pulmonary angiography and indirect CT venography. J Korean Med Sci (2009) 0.91

Incidence of deep vein thrombosis after major lower limb orthopedic surgery: analysis of a nationwide claim registry. Yonsei Med J (2015) 0.91

Evolving use of new oral anticoagulants for treatment of venous thromboembolism. Blood (2014) 0.90

Venous thromboembolism: classification, risk factors, diagnosis, and management. ISRN Hematol (2011) 0.89

Early stroke-related deep venous thrombosis: risk factors and influence on outcome. J Thromb Thrombolysis (2011) 0.89

Does intermittent pneumatic compression reduce the risk of post stroke deep vein thrombosis? The CLOTS 3 trial: study protocol for a randomized controlled trial. Trials (2012) 0.87

Combined magnetic resonance imaging of deep venous thrombosis and pulmonary arteries after a single injection of a blood pool contrast agent. Eur Radiol (2010) 0.87

Management and monitoring of anticoagulation for children undergoing cardiopulmonary bypass in cardiac surgery. J Extra Corpor Technol (2010) 0.87

Benefit vs. Risk of a Permanent Inferior Vena Cava Filter in Pulmonary Embolism with Anticoagulation Contraindication. Maedica (Buchar) (2013) 0.86

Impact of venous thromboembolism on clinical management and therapy after hip and knee arthroplasty. Can J Surg (2011) 0.85

Cost-effectiveness of bazedoxifene incorporating the FRAX® algorithm in a European perspective. Osteoporos Int (2010) 0.84

The role of noninvasive and invasive diagnostic imaging techniques for detection of extra-cranial venous system anomalies and developmental variants. BMC Med (2013) 0.84

High hematocrit as a risk factor for venous thrombosis. Cause or innocent bystander? Haematologica (2010) 0.84

Implementation of Pharmaceutical Practice Guidelines by a Project Model Based: Clinical and Economic Impact. Medicine (Baltimore) (2015) 0.84

Guided antithrombotic therapy: current status and future research direction: report on a National Heart, Lung and Blood Institute working group. Circulation (2012) 0.83

Simplifying thromboprophylaxis could improve outcomes in orthopaedic surgery. Thrombosis (2010) 0.82

Oral heparin: status review. Thromb J (2006) 0.82

Recurrent venous thromboembolism: what is the risk and how to prevent it. Scientifica (Cairo) (2012) 0.82

Primary thromboprophylaxis for cancer patients with central venous catheters--a reappraisal of the evidence. Br J Cancer (2006) 0.81

Venous thromboembolism in patients with reduced estimated GFR: a population-based perspective. Am J Kidney Dis (2011) 0.81

Acute lung failure. Semin Respir Crit Care Med (2011) 0.81

Rivaroxaban for the treatment of pulmonary embolism. Adv Ther (2013) 0.81

Venous thromboembolism in cirrhosis. Clin Appl Thromb Hemost (2012) 0.80

Changing practice: implementation of a venous thromboembolism prophylaxis protocol at an academic medical center. Plast Reconstr Surg (2011) 0.80

Expanding use of new oral anticoagulants. F1000Prime Rep (2014) 0.80

Investigating the benefit of adding a vena cava filter to anticoagulation with fondaparinux sodium in patients with cancer and venous thromboembolism in a prospective randomized clinical trial. Support Care Cancer (2012) 0.80

Ultrasound screening for deep venous thrombosis detection: a prospective evaluation of 200 plastic surgery outpatients. Plast Reconstr Surg Glob Open (2015) 0.80

Management of Venous Thromboembolisms: Part I. The Consensus for Deep Vein Thrombosis. Zhonghua Minguo Xin Zang Xue Hui Za Zhi (2016) 0.80

The true treatment benefit is unpredictable in clinical trials using surrogate outcome measured with diagnostic tests. J Clin Epidemiol (2005) 0.80

Catheter-directed thrombolysis for the treatment of symptomatic deep vein thrombosis. Circulation (2004) 0.79

Benefit-risk assessment of rivaroxaban versus enoxaparin for the prevention of venous thromboembolism after total hip or knee arthroplasty. Vasc Health Risk Manag (2014) 0.79

Pancreatic cancer and thromboembolic disease, 150 years after Trousseau. Hepatobiliary Surg Nutr (2015) 0.79

New options with dabigatran etexilate in anticoagulant therapy. Vasc Health Risk Manag (2010) 0.79

Efficiency and effectiveness of the use of an acenocoumarol pharmacogenetic dosing algorithm versus usual care in patients with venous thromboembolic disease initiating oral anticoagulation: study protocol for a randomized controlled trial. Trials (2012) 0.79

Direct Thrombus Imaging in Stroke. J Stroke (2016) 0.78

Venous thromboembolic prophylaxis for hip fractures. Osteoporos Int (2010) 0.78

New oral anticoagulants in the treatment of pulmonary embolism: efficacy, bleeding risk, and monitoring. Thrombosis (2013) 0.78

Multiple ligament knee injury: complications. N Am J Sports Phys Ther (2008) 0.78

Canadian consensus recommendations on the management of venous thromboembolism in patients with cancer. Part 2: treatment. Curr Oncol (2015) 0.78

Treatment of venous thromboembolism - effects of different therapeutic strategies on bleeding and recurrence rates and considerations for future anticoagulant management. Thromb J (2012) 0.78

Current and emerging strategies in the management of venous thromboembolism: benefit-risk assessment of dabigatran. Vasc Health Risk Manag (2015) 0.78

Left ventricular strain and strain rate by 2D speckle tracking in chronic thromboembolic pulmonary hypertension before and after pulmonary thromboendarterectomy. Cardiovasc Ultrasound (2010) 0.78

Direct oral anticoagulants in the treatment of venous thromboembolism, with a focus on patients with pulmonary embolism: an evidence-based review. Vasc Health Risk Manag (2014) 0.77

New orally active anticoagulant agents for the prevention and treatment of venous thromboembolism in cancer patients. Ther Clin Risk Manag (2014) 0.77

Clinical probability and risk analysis of patients with suspected pulmonary embolism. World J Emerg Med (2014) 0.77

Impact of the national venous thromboembolism risk assessment tool in secondary care in England: retrospective population-based database study. Blood Coagul Fibrinolysis (2014) 0.77

Hokusai-VTE: Edoxaban for the treatment of venous thromboembolism. Glob Cardiol Sci Pract (2013) 0.76

The Efficacy of Low Molecular Weight Heparin for the Prevention of Venous Thromboembolism after Hip Fracture Surgery in Korean Patients. Yonsei Med J (2016) 0.75

Factors predicting venous thromboembolism after spine surgery. Medicine (Baltimore) (2016) 0.75

Multiple pulmonary emboli as a result of renal cell carcinoma: A case report. Oncol Lett (2016) 0.75

Interdisciplinary management of deep vein thrombosis during rehabilitation of acute rupture of the anterior cruciate ligament: a case report. J Chiropr Med (2014) 0.75

Asymptomatic deep vein thrombosis in a patient with major depressive disorder. Case Rep Psychiatry (2012) 0.75

New oral anticoagulants for thromboprophylaxis after elective total hip and knee arthroplasty. Thrombosis (2010) 0.75

SUPRA AND INTRACONDYLAR OPEN FRACTURE OF THE FEMUR IN A MOTOCROSS ATHLETE: CASE REPORT. Rev Bras Ortop (2015) 0.75

Hospitalization for pulmonary embolism associated with antecedent testosterone or estrogen therapy in patients found to have familial and acquired thrombophilia. BMC Hematol (2016) 0.75

Impact of thromboprophylaxis across the US acute care setting. PLoS One (2015) 0.75

Deep Vein Thrombosis in Patients with Pulmonary Embolism: Prevalance, Clinical Significance and Outcome. Vasc Specialist Int (2016) 0.75

Analysis of contributing factors influencing thromboembolic events after total knee arthroplasty. Can J Surg (2017) 0.75

Factors XI and XII as Targets for New Anticoagulants. Front Med (Lausanne) (2017) 0.75

Venous thromboprophylaxis in gastrointestinal bleeding. Can J Gastroenterol Hepatol (2015) 0.75

Incidence of venous thromboembolism in care homes: a prospective cohort study. Br J Gen Pract (2017) 0.75

Intermittent pneumatic compression devices combined with anticoagulants for prevention of symptomatic deep vein thrombosis after total knee arthroplasty: a pilot study. Ther Clin Risk Manag (2017) 0.75

Multiple Venous Thromboses Presenting as Mechanical Low Back Pain in an 18-Year-Old Woman. J Chiropr Med (2015) 0.75

Benefits of novel oral anticoagulant agents for thromboprophylaxis after total hip or knee arthroplasty. Am Health Drug Benefits (2012) 0.75

Emergency Department Management of Suspected Calf-Vein Deep Venous Thrombosis: A Diagnostic Algorithm. West J Emerg Med (2016) 0.75

Critical appraisal of dabigatran in the treatment of deep vein thrombosis and pulmonary embolism. J Blood Med (2015) 0.75

Five-year follow-up of pulmonary embolism under anticoaugulation: The PISA-PEET (Pulmonary Embolism Extension Therapy) study. Medicine (Baltimore) (2016) 0.75

Study of clinical profile and management of patients with pulmonary embolism - single center study. Indian Heart J (2014) 0.75

Stopping anticoagulant therapy after an unprovoked venous thromboembolism. CMAJ (2008) 0.75

Postoperative Complications After Coronary Artery Bypass Grafting in Patients With Chronic Obstructive Pulmonary Disease. Medicine (Baltimore) (2016) 0.75

Venous Thromboembolism following Elective Aesthetic Plastic Surgery: A Longitudinal Prospective Study in 1254 Patients. Plast Surg Int (2014) 0.75

Managing pulmonary embolism using prognostic models: future concepts for primary care. CMAJ (2011) 0.75

A new diagnostic marker for acute pulmonary embolism in emergency department: mean platelet volume. Afr Health Sci (2014) 0.75

Comparison of thromboprophylaxis patterns in arthroplasty in public and private hospitals. Einstein (Sao Paulo) (2015) 0.75

Deep Vein Thrombosis in the Lower Extremities in Comatose Elderly Patients with Acute Neurological Diseases. Yonsei Med J (2016) 0.75

Timing of deep vein thrombosis formation after aneurysmal subarachnoid hemorrhage. J Neurosurg (2015) 0.75

Safety in the operating theatre--a transition to systems-based care. Nat Rev Urol (2013) 0.75

Unfractionated heparin and mechanical thromboprophylaxis in hip arthroplasty. Acta Ortop Bras (2015) 0.75

Recent advances in the treatment of venous thromboembolism in the era of the direct oral anticoagulants. F1000Res (2017) 0.75

3rd Guideline for Perioperative Cardiovascular Evaluation of the Brazilian Society of Cardiology. Arq Bras Cardiol (2017) 0.75

Assessment of quality of life, satisfaction with anticoagulation therapy, and adherence to treatment in patients receiving long-course vitamin K antagonists or direct oral anticoagulants for venous thromboembolism. Patient Prefer Adherence (2017) 0.75

Arq Bras Cardiol (2017) 0.75